{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T19:20:37Z","timestamp":1793992837963,"version":"4.8.0"},"reference-count":112,"publisher":"American Medical Association (AMA)","issue":"23","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2018,12,18]]},"DOI":"10.1001\/jama.2018.18472","type":"journal-article","created":{"date-parts":[[2018,12,18]],"date-time":"2018-12-18T16:02:44Z","timestamp":1545148964000},"page":"2448","source":"Crossref","is-referenced-by-count":665,"title":["Opioids for Chronic Noncancer Pain"],"prefix":"10.1001","volume":"320","author":[{"given":"Jason W.","family":"Busse","sequence":"first","affiliation":[{"name":"Michael G. DeGroote Institute for Pain Research and Care, McMaster University, Hamilton, Ontario, Canada"},{"name":"Department of Anesthesia, McMaster University, Hamilton, Ontario, Canada"},{"name":"Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada"},{"name":"Michael G. DeGroote Centre for Medicinal Cannabis Research, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[{"name":"Michael G. DeGroote Institute for Pain Research and Care, McMaster University, Hamilton, Ontario, Canada"},{"name":"Department of Anesthesia, McMaster University, Hamilton, Ontario, Canada"},{"name":"Chinese Cochrane Centre, West China Hospital, Sichuan University, Chengdu"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mostafa","family":"Kamaleldin","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Ain Shams University, Cairo, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Craigie","sequence":"additional","affiliation":[{"name":"Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"Riva","sequence":"additional","affiliation":[{"name":"Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada"},{"name":"Department of Family Medicine, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Montoya","sequence":"additional","affiliation":[{"name":"Krembil Research Institute, University Health Network, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sohail M.","family":"Mulla","sequence":"additional","affiliation":[{"name":"Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada"},{"name":"Now with the Canadian Agency for Drugs and Technologies in Health (CADTH), Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciane C.","family":"Lopes","sequence":"additional","affiliation":[{"name":"Pharmaceutical Science, University of Sorocaba, Sao Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Vogel","sequence":"additional","affiliation":[{"name":"Leonardo Hirslanden Klinik Birshof, M\u00fcnchenstein, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Chen","sequence":"additional","affiliation":[{"name":"Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Kirmayr","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Hospital Alem\u00e1n de Buenos Aires, Buenos Aires, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle","family":"De Oliveira","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Pain Medicine, University of Ottawa, Ottawa, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori","family":"Olivieri","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Perioperative and Pain Medicine, University of Calgary, Calgary, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alka","family":"Kaushal","sequence":"additional","affiliation":[{"name":"Michael G. DeGroote Institute for Pain Research and Care, McMaster University, Hamilton, Ontario, Canada"},{"name":"Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada"},{"name":"Department of Family Medicine, Max Rady College of Medicine, University of Manitoba, Winnipeg, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis E.","family":"Chaparro","sequence":"additional","affiliation":[{"name":"Department of Anesthesia, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inna","family":"Oyberman","sequence":"additional","affiliation":[{"name":"Department of Anesthesia, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnav","family":"Agarwal","sequence":"additional","affiliation":[{"name":"Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada"},{"name":"Department of Medicine, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Couban","sequence":"additional","affiliation":[{"name":"Michael G. DeGroote Institute for Pain Research and Care, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludwig","family":"Tsoi","sequence":"additional","affiliation":[{"name":"Accident and Emergency Department, Queen Mary Hospital, Pokfulam, Hong Kong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommy","family":"Lam","sequence":"additional","affiliation":[{"name":"Accident and Emergency Department, Tuen Mun Hospital, Hong Kong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per Olav","family":"Vandvik","sequence":"additional","affiliation":[{"name":"Department of Medicine, Gj\u00f8vik, Innlandet Hospital Trust, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandy","family":"Hsu","sequence":"additional","affiliation":[{"name":"Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malgorzata M.","family":"Bala","sequence":"additional","affiliation":[{"name":"Department of Hygiene and Dietetics, Faculty of Medicine, Jagiellonian University Medical College, Krakow, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Schandelmaier","sequence":"additional","affiliation":[{"name":"Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada"},{"name":"Institute for Clinical Epidemiology and Biostatistics, University of Basel Hospital, Basel, Switzerland"},{"name":"Department of Clinical Research, University of Basel Hospital, Basel, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Scheidecker","sequence":"additional","affiliation":[{"name":"Department of Anesthesia, McMaster University, Hamilton, Ontario, Canada"},{"name":"Department of Anesthesiology, Operative Intensive Care, Preclinical Emergency Medicine and Pain Management, University of Basel Hospital, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanil","family":"Ebrahim","sequence":"additional","affiliation":[{"name":"Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vahid","family":"Ashoorion","sequence":"additional","affiliation":[{"name":"Michael G. DeGroote Institute for Pain Research and Care, McMaster University, Hamilton, Ontario, Canada"},{"name":"Isfahan Medical Education Research Centre, Isfahan University of Medical Sciences, Isfahan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasir","family":"Rehman","sequence":"additional","affiliation":[{"name":"Michael G. DeGroote Institute for Pain Research and Care, McMaster University, Hamilton, Ontario, Canada"},{"name":"Canadian Academy of Osteopathy, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick J.","family":"Hong","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Ross","sequence":"additional","affiliation":[{"name":"Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley C.","family":"Johnston","sequence":"additional","affiliation":[{"name":"Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada"},{"name":"Department of Community Health and Epidemiology, Dalhousie University, Halifax, Nova Scotia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regina","family":"Kunz","sequence":"additional","affiliation":[{"name":"Department of Clinical Research, University of Basel Hospital, Basel, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada"},{"name":"Chinese Cochrane Centre, West China Hospital, Sichuan University, Chengdu"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norman","family":"Buckley","sequence":"additional","affiliation":[{"name":"Michael G. DeGroote Institute for Pain Research and Care, McMaster University, Hamilton, Ontario, Canada"},{"name":"Department of Anesthesia, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel I.","family":"Sessler","sequence":"additional","affiliation":[{"name":"Department of Outcomes Research, Anesthesiology Institute, Cleveland Clinic, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon H.","family":"Guyatt","sequence":"additional","affiliation":[{"name":"Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"36","key":"joi180142r1","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.15585\/mmwr.mm6736a2","article-title":"Prevalence of chronic pain and high-impact chronic pain among adults\u2014United States, 2016.","volume":"67","author":"Dahlhamer","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"joi180142r2","doi-asserted-by":"publisher","first-page":"221","DOI":"10.2105\/AJPH.2007.131714","article-title":"The promotion and marketing of oxycontin: commercial triumph, public health tragedy.","volume":"99","author":"Van Zee","year":"2009","journal-title":"Am J Public Health"},{"issue":"13","key":"joi180142r3","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1056\/NEJMra1507771","article-title":"Opioid abuse in chronic pain.","volume":"374","author":"Volkow","year":"2016","journal-title":"N Engl J Med"},{"issue":"1","key":"joi180142r4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr6501e1","article-title":"CDC guideline for prescribing opioids for chronic pain\u2014United States, 2016.","volume":"65","author":"Dowell","year":"2016","journal-title":"MMWR Recomm Rep"},{"issue":"14","key":"joi180142r8","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1001\/jama.2015.11859","article-title":"Nonmedical prescription opioid use and use disorders among adults aged 18 through 64 years in the United States, 2003-2013.","volume":"314","author":"Han","year":"2015","journal-title":"JAMA"},{"issue":"4","key":"joi180142r9","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1097\/01.j.pain.0000460357.01998.f1","article-title":"Rates of opioid misuse, abuse, and addiction in chronic pain.","volume":"156","author":"Vowles","year":"2015","journal-title":"Pain"},{"issue":"22","key":"joi180142r10","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1001\/jama.2016.7789","article-title":"Prescription of long-acting opioids and mortality in patients with chronic noncancer pain.","volume":"315","author":"Ray","year":"2016","journal-title":"JAMA"},{"issue":"4","key":"joi180142r11","doi-asserted-by":"publisher","first-page":"276","DOI":"10.7326\/M14-2559","article-title":"The effectiveness and risks of long-term opioid therapy for chronic pain.","volume":"162","author":"Chou","year":"2015","journal-title":"Ann Intern Med"},{"issue":"5","key":"joi180142r12","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1155\/2011\/465281","article-title":"A comparison between enriched and nonenriched enrollment randomized withdrawal trials of opioids for chronic noncancer pain.","volume":"16","author":"Furlan","year":"2011","journal-title":"Pain Res Manag"},{"issue":"10","key":"joi180142r13","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.3899\/jrheum.141440","article-title":"Optimal strategies for reporting pain in clinical trials and systematic reviews.","volume":"42","author":"Busse","year":"2015","journal-title":"J Rheumatol"},{"key":"joi180142r14","doi-asserted-by":"publisher","first-page":"c117","DOI":"10.1136\/bmj.c117","article-title":"Is a subgroup effect believable? updating criteria to evaluate the credibility of subgroup analyses.","volume":"340","author":"Sun","year":"2010","journal-title":"BMJ"},{"issue":"5","key":"joi180142r15","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.ijsu.2010.02.007","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.","volume":"8","author":"Moher","year":"2010","journal-title":"Int J Surg"},{"issue":"66","key":"joi180142r16","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/2046-4053-2-66","article-title":"Opioids for chronic non-cancer pain.","volume":"2","author":"Busse","year":"2013","journal-title":"Syst Rev"},{"issue":"3","key":"joi180142r17","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.pain.2003.08.001","article-title":"Core outcome domains for chronic pain clinical trials: IMMPACT recommendations.","volume":"106","author":"Turk","year":"2003","journal-title":"Pain"},{"issue":"2","key":"joi180142r18","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.pain.2007.09.002","article-title":"Identifying important outcome domains for chronic pain clinical trials.","volume":"137","author":"Turk","year":"2008","journal-title":"Pain"},{"key":"joi180142r19","article-title":"Patient values and preferences regarding opioids for chronic noncancer pain: a systematic review","author":"Goshua","journal-title":"Pain Med"},{"issue":"6","key":"joi180142r20","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1002\/pds.3945","article-title":"A synthesis of oral morphine equivalents (OME) for opioid utilisation studies.","volume":"25","author":"Nielsen","year":"2016","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"joi180142r21","doi-asserted-by":"publisher","first-page":"d4829","DOI":"10.1136\/bmj.d4829","article-title":"Multiplicity of data in trial reports and the reliability of meta-analyses: empirical study.","volume":"343","author":"Tendal","year":"2011","journal-title":"BMJ"},{"issue":"3","key":"joi180142r22","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.jclinepi.2011.04.015","article-title":"Specific instructions for estimating unclearly reported blinding status in randomized trials were reliable and valid.","volume":"65","author":"Akl","year":"2012","journal-title":"J Clin Epidemiol"},{"key":"joi180142r23","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials.","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"issue":"1","key":"joi180142r24","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2307\/2529310","article-title":"The measurement of observer agreement for categorical data.","volume":"33","author":"Landis","year":"1977","journal-title":"Biometrics"},{"issue":"3","key":"joi180142r25","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1002\/jrsm.v2.3","article-title":"Pooling health-related quality of life outcomes in meta-analysis\u2014a tutorial and review of methods for enhancing interpretability.","volume":"2","author":"Thorlund","year":"2011","journal-title":"Res Synth Methods"},{"issue":"2","key":"joi180142r26","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1111\/hesr.2005.40.issue-2","article-title":"Commentary\u2014goodbye M(C)ID! hello MID, where do you come from?","volume":"40","author":"Sch\u00fcnemann","year":"2005","journal-title":"Health Serv Res"},{"issue":"2","key":"joi180142r27","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jpain.2007.09.005","article-title":"Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations.","volume":"9","author":"Dworkin","year":"2008","journal-title":"J Pain"},{"issue":"12","key":"joi180142r28","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1002\/acr.v66.12","article-title":"Clinically important changes in Short Form 36 health survey scales for use in rheumatoid arthritis clinical trials.","volume":"66","author":"Ward","year":"2014","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"joi180142r30","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1471-2288-14-25","article-title":"The Hartung-Knapp-Sidik-Jonkman method for random effects meta-analysis is straightforward and considerably outperforms the standard DerSimonian-Laird method.","volume":"14","author":"IntHout","year":"2014","journal-title":"BMC Med Res Methodol"},{"issue":"18","key":"joi180142r32","doi-asserted-by":"publisher","first-page":"E659","DOI":"10.1503\/cmaj.170363","article-title":"Guideline for opioid therapy and chronic noncancer pain.","volume":"189","author":"Busse","year":"2017","journal-title":"CMAJ"},{"issue":"7650","key":"joi180142r33","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations.","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"issue":"4","key":"joi180142r35","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.2307\/2533446","article-title":"Operating characteristics of a rank correlation test for publication bias.","volume":"50","author":"Begg","year":"1994","journal-title":"Biometrics"},{"issue":"4","key":"joi180142r36","first-page":"862","article-title":"Treatment of osteoarthritis pain with controlled release oxycodone or fixed combination oxycodone plus acetaminophen added to nonsteroidal antiinflammatory drugs.","volume":"26","author":"Caldwell","year":"1999","journal-title":"J Rheumatol"},{"issue":"2","key":"joi180142r37","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1155\/2013\/164609","article-title":"Controlled-release oxycodone and naloxone in the treatment of chronic low back pain: a placebo-controlled, randomized study","volume":"18","author":"Cloutier","year":"2013","journal-title":"Pain Res Manag"},{"issue":"6","key":"joi180142r38","doi-asserted-by":"publisher","first-page":"507","DOI":"10.5055\/jom.2015.0304","article-title":"Efficacy and safety of a hydrocodone extended-release tablet formulated with abuse-deterrence technology in patients with moderate-to-severe chronic low back pain.","volume":"11","author":"Hale","year":"2015","journal-title":"J Opioid Manag"},{"issue":"23","key":"joi180142r39","doi-asserted-by":"publisher","first-page":"2591","DOI":"10.1097\/00007632-199812010-00014","article-title":"Opioid therapy for chronic noncancer back pain: a randomized prospective study.","volume":"23","author":"Jamison","year":"1998","journal-title":"Spine (Phila Pa 1976)"},{"issue":"1-2","key":"joi180142r40","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.pain.2006.10.029","article-title":"Morphine, nortriptyline and their combination vs placebo in patients with chronic lumbar root pain.","volume":"130","author":"Khoromi","year":"2007","journal-title":"Pain"},{"issue":"12","key":"joi180142r41","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.jpain.2006.05.005","article-title":"Oxytrex minimizes physical dependence while providing effective analgesia.","volume":"7","author":"Webster","year":"2006","journal-title":"J Pain"},{"issue":"11","key":"joi180142r42","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.1097\/j.pain.0000000000000670","article-title":"Efficacy and tolerability of buccal buprenorphine in opioid-experienced patients with moderate to severe chronic low back pain","volume":"157","author":"Gimbel","year":"2016","journal-title":"Pain"},{"issue":"8","key":"joi180142r43","doi-asserted-by":"publisher","first-page":"489","DOI":"10.2165\/11533440-000000000-00000","article-title":"Efficacy and safety of tapentadol extended release compared with oxycodone controlled release for the management of moderate to severe chronic pain related to osteoarthritis of the knee.","volume":"30","author":"Afilalo","year":"2010","journal-title":"Clin Drug Investig"},{"issue":"12","key":"joi180142r44","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1185\/03007995.2015.1092127","article-title":"Two placebo-controlled, randomized withdrawal studies to evaluate the fentanyl 1 day patch in opioid-na\u00efve patients with chronic pain.","volume":"31","author":"Arai","year":"2015","journal-title":"Curr Med Res Opin"},{"issue":"1","key":"joi180142r45","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jpainsymman.2003.11.006","article-title":"Efficacy and safety of extended-release, once-daily tramadol in chronic pain.","volume":"28","author":"Babul","year":"2004","journal-title":"J Pain Symptom Manage"},{"issue":"7","key":"joi180142r46","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/S0002-9343(03)00116-5","article-title":"Tramadol and acetaminophen combination tablets in the treatment of fibromyalgia pain.","volume":"114","author":"Bennett","year":"2003","journal-title":"Am J Med"},{"issue":"3","key":"joi180142r47","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.sjpain.2010.05.035","article-title":"A 6-months, randomised, placebo-controlled evaluation of efficacy and tolerability of a low-dose 7-day buprenorphine transdermal patch in osteoarthritis patients na\u00efve to potent opioids.","volume":"1","author":"Breivik","year":"2010","journal-title":"Scand J Pain"},{"issue":"3","key":"joi180142r48","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.jpainsymman.2006.11.017","article-title":"A comparison of the analgesic efficacy of tramadol contramid OAD versus placebo in patients with pain due to osteoarthritis.","volume":"34","author":"Burch","year":"2007","journal-title":"J Pain Symptom Manage"},{"issue":"11","key":"joi180142r49","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1517\/14656566.2010.497720","article-title":"Efficacy and safety of tapentadol extended release for the management of chronic low back pain.","volume":"11","author":"Buynak","year":"2010","journal-title":"Expert Opin Pharmacother"},{"issue":"9","key":"joi180142r50","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1097\/j.pain.0000000000000986","article-title":"Cebranopadol, a novel first-in-class analgesic drug candidate.","volume":"158","author":"Christoph","year":"2017","journal-title":"Pain"},{"issue":"3","key":"joi180142r51","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1097\/MJT.0b013e3181cec307","article-title":"Tramadol hydrochloride extended-release once-daily in the treatment of osteoarthritis of the knee and\/or hip.","volume":"18","author":"DeLemos","year":"2011","journal-title":"Am J Ther"},{"issue":"1","key":"joi180142r52","first-page":"150","article-title":"Efficacy and safety of tramadol\/acetaminophen tablets (ultracet) as add-on therapy for osteoarthritis pain in subjects receiving a COX-2 nonsteroidal antiinflammatory drug.","volume":"31","author":"Emkey","year":"2004","journal-title":"J Rheumatol"},{"issue":"5","key":"joi180142r53","doi-asserted-by":"publisher","first-page":"273","DOI":"10.5055\/jom.2007.0015","article-title":"Efficacy and safety of 12 weeks of osteoarthritic pain therapy with once-daily tramadol (tramadol contramid OAD).","volume":"3","author":"Fishman","year":"2007","journal-title":"J Opioid Manag"},{"issue":"2","key":"joi180142r54","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0011-393X(01)80021-7","article-title":"Tramadol for the treatment of joint pain associated with osteoarthritis.","volume":"62","author":"Fleischmann","year":"2001","journal-title":"Curr Ther Res Clin Exp"},{"issue":"3","key":"joi180142r55","doi-asserted-by":"publisher","first-page":"193","DOI":"10.5055\/jom","article-title":"Efficacy and safety of an extended-release oxycodone (remoxy) formulation in patients with moderate to severe osteoarthritic pain.","volume":"7","author":"Friedmann","year":"2011","journal-title":"J Opioid Manag"},{"issue":"7","key":"joi180142r56","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1185\/030079906X115595","article-title":"Extended-release tramadol in the treatment of osteoarthritis.","volume":"22","author":"Gana","year":"2006","journal-title":"Curr Med Res Opin"},{"issue":"6","key":"joi180142r57","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1185\/03007995.2010.484723","article-title":"Once-daily OROS hydromorphone ER compared with placebo in opioid-tolerant patients with chronic low back pain.","volume":"26","author":"Hale","year":"2010","journal-title":"Curr Med Res Opin"},{"issue":"2","key":"joi180142r58","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.jpain.2006.09.011","article-title":"Efficacy and safety of OPANA ER (oxymorphone extended release) for relief of moderate to severe chronic low back pain in opioid-experienced patients.","volume":"8","author":"Hale","year":"2007","journal-title":"J Pain"},{"issue":"6","key":"joi180142r59","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/j.ejpain.2007.12.010","article-title":"Prolonged-release oxycodone enhances the effects of existing gabapentin therapy in painful diabetic neuropathy patients.","volume":"12","author":"Hanna","year":"2008","journal-title":"Eur J Pain"},{"issue":"4","key":"joi180142r60","doi-asserted-by":"publisher","first-page":"112","DOI":"10.3810\/pgm.2010.07.2179","article-title":"Morphine sulfate and naltrexone hydrochloride extended release capsules in patients with chronic osteoarthritis pain.","volume":"122","author":"Katz","year":"2010","journal-title":"Postgrad Med"},{"issue":"12","key":"joi180142r61","doi-asserted-by":"publisher","first-page":"2458","DOI":"10.1097\/j.pain.0000000000000315","article-title":"A phase 3, multicenter, randomized, double-blind, placebo-controlled, safety, tolerability, and efficacy study of Xtampza ER in patients with moderate-to-severe chronic low back pain.","volume":"156","author":"Katz","year":"2015","journal-title":"Pain"},{"issue":"1","key":"joi180142r62","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1185\/030079906X162692","article-title":"A 12-week, randomized, placebo-controlled trial assessing the safety and efficacy of oxymorphone extended release for opioid-naive patients with chronic low back pain.","volume":"23","author":"Katz","year":"2007","journal-title":"Curr Med Res Opin"},{"issue":"6","key":"joi180142r63","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1111\/ijcp.2016.70.issue-6","article-title":"Efficacy and safety of fulranumab as monotherapy in patients with moderate to severe, chronic knee pain of primary osteoarthritis.","volume":"70","author":"Mayorga","year":"2016","journal-title":"Int J Clin Pract"},{"issue":"12","key":"joi180142r64","first-page":"2454","article-title":"Analgesic efficacy and safety of tramadol\/acetaminophen combination tablets (ultracet) in treatment of chronic low back pain.","volume":"31","author":"Peloso","year":"2004","journal-title":"J Rheumatol"},{"issue":"1","key":"joi180142r65","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/papr.2012.13.issue-1","article-title":"Results of a double-blind, placebo-controlled, fixed-dose assessment of once-daily OROS\u00ae hydromorphone ER in patients with moderate to severe pain associated with chronic osteoarthritis.","volume":"13","author":"Rauck","year":"2013","journal-title":"Pain Pract"},{"issue":"9","key":"joi180142r66","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1097\/j.pain.0000000000000230","article-title":"A randomized double-blind, placebo-controlled efficacy and safety study of ALO-02 (extended-release oxycodone surrounding sequestered naltrexone) for moderate-to-severe chronic low back pain treatment.","volume":"156","author":"Rauck","year":"2015","journal-title":"Pain"},{"issue":"6","key":"joi180142r67","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1111\/pme.12377","article-title":"Single-entity hydrocodone extended-release capsules in opioid-tolerant subjects with moderate-to-severe chronic low back pain.","volume":"15","author":"Rauck","year":"2014","journal-title":"Pain Med"},{"issue":"1","key":"joi180142r68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/00325481.2016.1128307","article-title":"Efficacy and tolerability of buccal buprenorphine in opioid-naive patients with moderate to severe chronic low back pain.","volume":"128","author":"Rauck","year":"2016","journal-title":"Postgrad Med"},{"issue":"4","key":"joi180142r69","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/S0149-2918(03)80071-1","article-title":"Tramadol\/acetaminophen combination tablets for the treatment of chronic lower back pain.","volume":"25","author":"Ruoff","year":"2003","journal-title":"Clin Ther"},{"issue":"1","key":"joi180142r70","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1185\/03007995.2010.537589","article-title":"Safety and efficacy of tapentadol ER in patients with painful diabetic peripheral neuropathy.","volume":"27","author":"Schwartz","year":"2011","journal-title":"Curr Med Res Opin"},{"issue":"8","key":"joi180142r71","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1080\/03007995.2017.1335189","article-title":"Tapentadol prolonged-release for moderate-to-severe chronic osteoarthritis knee pain.","volume":"33","author":"Serrie","year":"2017","journal-title":"Curr Med Res Opin"},{"issue":"9","key":"joi180142r72","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.2337\/dc16-0123","article-title":"Transdermal buprenorphine relieves neuropathic pain.","volume":"39","author":"Simpson","year":"2016","journal-title":"Diabetes Care"},{"issue":"6","key":"joi180142r73","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.jpainsymman.2011.04.006","article-title":"Efficacy and safety of the seven-day buprenorphine transdermal system in opioid-na\u00efve patients with moderate to severe chronic low back pain.","volume":"42","author":"Steiner","year":"2011","journal-title":"J Pain Symptom Manage"},{"issue":"7","key":"joi180142r74","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1055\/s-00023610","article-title":"Methodological issues in conducting pilot trials in chronic pain as randomized, double-blind, placebo-controlled studies.","volume":"66","author":"Tominaga","year":"2016","journal-title":"Drug Res (Stuttg)"},{"issue":"12","key":"joi180142r75","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/S1474-4422(15)00243-4","article-title":"Prolonged-release oxycodone-naloxone for treatment of severe pain in patients with Parkinson\u2019s disease (PANDA).","volume":"14","author":"Trenkwalder","year":"2015","journal-title":"Lancet Neurol"},{"issue":"8","key":"joi180142r76","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.2337\/dc13-2291","article-title":"A randomized withdrawal, placebo-controlled study evaluating the efficacy and tolerability of tapentadol extended release in patients with chronic painful diabetic peripheral neuropathy.","volume":"37","author":"Vinik","year":"2014","journal-title":"Diabetes Care"},{"key":"joi180142r77","first-page":"239501","article-title":"A phase IIIb, multicentre, randomised, parallel-group, placebo-controlled, double-blind study to investigate the efficacy and safety of OROS hydromorphone in subjects with moderate-to-severe chronic pain induced by osteoarthritis of the hip or the knee.","volume":"2011","author":"Vojta\u0161\u0161\u00e1k","year":"2011","journal-title":"Pain Res Treat"},{"issue":"2","key":"joi180142r78","doi-asserted-by":"publisher","first-page":"87","DOI":"10.5055\/jom.2008.0013","article-title":"Extended-release tramadol (tramadol ER) in the treatment of chronic low back pain.","volume":"4","author":"Vorsanger","year":"2008","journal-title":"J Opioid Manag"},{"issue":"1","key":"joi180142r79","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/s12955-017-0749-y","article-title":"Patient-reported health-related quality of life, work productivity, and activity impairment during treatment with ALO-02 (extended-release oxycodone and sequestered naltrexone) for moderate-to-severe chronic low back pain.","volume":"15","author":"Weil","year":"2017","journal-title":"Health Qual Life Outcomes"},{"issue":"11","key":"joi180142r80","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1517\/14656566.2015.1060221","article-title":"A multicenter, randomized, double-blind, placebo-controlled trial to assess the efficacy and safety of single-entity, once-daily hydrocodone tablets in patients with uncontrolled moderate to severe chronic low back pain.","volume":"16","author":"Wen","year":"2015","journal-title":"Expert Opin Pharmacother"},{"issue":"4","key":"joi180142r81","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/S0885-3924(02)00383-4","article-title":"Efficacy and safety of a once-daily morphine formulation in chronic, moderate-to-severe osteoarthritis pain.","volume":"23","author":"Caldwell","year":"2002","journal-title":"J Pain Symptom Manage"},{"issue":"8","key":"joi180142r82","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1016\/j.pain.2012.02.028","article-title":"Analgesic tolerance without demonstrable opioid-induced hyperalgesia.","volume":"153","author":"Chu","year":"2012","journal-title":"Pain"},{"issue":"1","key":"joi180142r83","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1185\/030079906X162674","article-title":"Randomized study of tramadol\/acetaminophen versus placebo in painful diabetic peripheral neuropathy.","volume":"23","author":"Freeman","year":"2007","journal-title":"Curr Med Res Opin"},{"issue":"13","key":"joi180142r84","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1056\/NEJMoa042580","article-title":"Morphine, gabapentin, or their combination for neuropathic pain.","volume":"352","author":"Gilron","year":"2005","journal-title":"N Engl J Med"},{"issue":"8","key":"joi180142r85","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1097\/j.pain.0000000000000149","article-title":"Combination of morphine with nortriptyline for neuropathic pain.","volume":"156","author":"Gilron","year":"2015","journal-title":"Pain"},{"issue":"6","key":"joi180142r86","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1212\/01.WNL.0000057720.36503.2C","article-title":"Controlled-release oxycodone for pain in diabetic neuropathy.","volume":"60","author":"Gimbel","year":"2003","journal-title":"Neurology"},{"issue":"5","key":"joi180142r87","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.clinthera.2010.04.018","article-title":"Buprenorphine transdermal system in adults with chronic low back pain.","volume":"32","author":"Gordon","year":"2010","journal-title":"Clin Ther"},{"issue":"3","key":"joi180142r88","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1155\/2010\/216725","article-title":"Buprenorphine transdermal system for opioid therapy in patients with chronic low back pain.","volume":"15","author":"Gordon","year":"2010","journal-title":"Pain Res Manag"},{"issue":"6","key":"joi180142r89","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1212\/WNL.50.6.1842","article-title":"Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy.","volume":"50","author":"Harati","year":"1998","journal-title":"Neurology"},{"issue":"6","key":"joi180142r90","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1002\/(ISSN)1529-0131","article-title":"Transdermal fentanyl for improvement of pain and functioning in osteoarthritis.","volume":"54","author":"Langford","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"11","key":"joi180142r91","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1016\/j.clinthera.2013.09.017","article-title":"A randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of the extended-release tramadol hydrochloride\/acetaminophen fixed-dose combination tablet for the treatment of chronic low back pain.","volume":"35","author":"Lee","year":"2013","journal-title":"Clin Ther"},{"issue":"2","key":"joi180142r92","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/ijcp.2008.62.issue-2","article-title":"The efficacy of oxycodone for management of acute pain episodes in chronic neck pain patients.","volume":"62","author":"Ma","year":"2008","journal-title":"Int J Clin Pract"},{"issue":"5","key":"joi180142r93","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1111\/j.1526-4637.2005.00057.x","article-title":"Oxymorphone extended-release tablets relieve moderate to severe pain and improve physical function in osteoarthritis.","volume":"6","author":"Matsumoto","year":"2005","journal-title":"Pain Med"},{"key":"joi180142r94","first-page":"1","article-title":"MST continus tablets and pain control in severe rheumatoid arthritis.","volume":"2","author":"Moran","year":"1991","journal-title":"Br J Clin Res"},{"issue":"3","key":"joi180142r95","first-page":"764","article-title":"Double blind randomized placebo control trial of controlled release codeine in the treatment of osteoarthritis of the hip or knee.","volume":"27","author":"Peloso","year":"2000","journal-title":"J Rheumatol"},{"issue":"2","key":"joi180142r96","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1155\/2008\/165421","article-title":"A randomized, double-blind, crossover comparison of the efficacy and safety of oral controlled-release tramadol and placebo in patients with painful osteoarthritis.","volume":"13","author":"Thorne","year":"2008","journal-title":"Pain Res Manag"},{"issue":"10","key":"joi180142r97","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1185\/03007995.2012.726216","article-title":"Efficacy and safety of flupirtine modified release for the management of moderate to severe chronic low back pain.","volume":"28","author":"Uberall","year":"2012","journal-title":"Curr Med Res Opin"},{"issue":"5","key":"joi180142r98","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.jpain.2009.09.003","article-title":"A randomized, controlled trial of oxycodone versus placebo in patients with postherpetic neuralgia and painful diabetic neuropathy treated with pregabalin.","volume":"11","author":"Zin","year":"2010","journal-title":"J Pain"},{"issue":"6","key":"joi180142r99","doi-asserted-by":"publisher","first-page":"383","DOI":"10.5055\/jom.2014.0235","article-title":"Clinical interpretation of opioid tolerance versus opioid-induced hyperalgesia.","volume":"10","author":"Chen","year":"2014","journal-title":"J Opioid Manag"},{"issue":"1","key":"joi180142r100","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/s13181-015-0521-9","article-title":"Chronic pain, chronic opioid addiction: a complex nexus.","volume":"12","author":"Salsitz","year":"2016","journal-title":"J Med Toxicol"},{"issue":"2","key":"joi180142r101","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.pmr.2014.12.001","article-title":"Opioid therapy in chronic pain.","volume":"26","author":"Ballantyne","year":"2015","journal-title":"Phys Med Rehabil Clin N Am"},{"issue":"39","key":"joi180142r102","doi-asserted-by":"publisher","first-page":"E1222","DOI":"10.1503\/cmaj.170628","article-title":"Rethinking \u201cdoing well\u201d on chronic opioid therapy.","volume":"189","author":"Juurlink","year":"2017","journal-title":"CMAJ"},{"issue":"3","key":"joi180142r103","doi-asserted-by":"publisher","first-page":"e599","DOI":"10.1097\/PR9.0000000000000599","article-title":"The opioid epidemic and national guidelines for opioid therapy for chronic noncancer pain.","volume":"2","author":"H\u00e4user","year":"2017","journal-title":"Pain Rep"},{"issue":"2","key":"joi180142r104","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1136\/annrheumdis-2016-209724","article-title":"EULAR revised recommendations for the management of fibromyalgia.","volume":"76","author":"Macfarlane","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"22","key":"joi180142r105","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1001\/jama.2016.6753","article-title":"Avoiding opioid analgesics for treatment of chronic low back pain.","volume":"315","author":"Ballantyne","year":"2016","journal-title":"JAMA"},{"issue":"7","key":"joi180142r106","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1001\/jamainternmed.2016.1251","article-title":"Efficacy, tolerability, and dose-dependent effects of opioid analgesics for low back pain.","volume":"176","author":"Abdel Shaheed","year":"2016","journal-title":"JAMA Intern Med"},{"issue":"7132","key":"joi180142r107","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1136\/bmj.316.7132.690","article-title":"Interpreting treatment effects in randomised trials.","volume":"316","author":"Guyatt","year":"1998","journal-title":"BMJ"},{"issue":"2","key":"joi180142r108","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.jpain.2010.09.003","article-title":"A randomized trial of 2 prescription strategies for opioid treatment of chronic nonmalignant pain.","volume":"12","author":"Naliboff","year":"2011","journal-title":"J Pain"},{"issue":"9","key":"joi180142r109","first-page":"826","article-title":"Trends in high-dose opioid prescribing in Canada.","volume":"60","author":"Gomes","year":"2014","journal-title":"Can Fam Physician"},{"issue":"12","key":"joi180142r110","doi-asserted-by":"publisher","first-page":"e0167479","DOI":"10.1371\/journal.pone.0168658","article-title":"High-dose opioid prescribing and opioid-related hospitalization.","volume":"11","author":"Fernandes","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"joi180142r111","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/AJP.0b013e3181b99f35","article-title":"Trends in use of opioids for chronic noncancer pain among individuals with mental health and substance use disorders.","volume":"26","author":"Edlund","year":"2010","journal-title":"Clin J Pain"},{"issue":"4","key":"joi180142r112","doi-asserted-by":"publisher","first-page":"407","DOI":"10.3122\/jabfm.2017.04.170112","article-title":"Prescription opioid use among adults with mental health disorders in the United States.","volume":"30","author":"Davis","year":"2017","journal-title":"J Am Board Fam Med"},{"key":"joi180142r29","first-page":"507","volume-title":"Users' Guides to the Medical Literature: A Manual for Evidence-Based Clinical Practice","author":"Murad","year":"2015","edition":"3rd ed"},{"key":"joi180142r31","first-page":"529","volume-title":"Data Analysis Using Regression and Multilevel\/Hierarchical Models","author":"Gelman","year":"2007"},{"key":"joi180142r5","unstructured":"International Narcotics Control Board. Narcotic drugs: estimated world requirements for 2017: statistics for 2015. https:\/\/www.incb.org\/documents\/Narcotic-Drugs\/Technical-Publications\/2016\/Narcotic_Drugs_Publication_2016.pdf. Accessed October 25, 2018."},{"key":"joi180142r6","doi-asserted-by":"crossref","unstructured":"International Narcotics Control Board. Narcotic drugs: estimated world requirements for 2018: statistics for 2016. https:\/\/www.incb.org\/documents\/Narcotic-Drugs\/Technical-Publications\/2017\/Narcotic_drugs_technical_publication_2017.pdf. Accessed October 25, 2018.","DOI":"10.18356\/55c75c37-en-fr-es"},{"key":"joi180142r7","unstructured":"Centers for Disease Control and Prevention. Key messages: prescription opioid data. https:\/\/www.cdc.gov\/drugoverdose\/data\/prescribing.html. Accessed October 25, 2018."},{"key":"joi180142r34","unstructured":"HigginsJPT, GreenS, eds. Cochrane Handbook for Systematic Reviews of Interventions: version 5.1.0; updated March 2011. http:\/\/handbook-5-1.cochrane.org\/. Accessed October 25, 2018."}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2718795","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,12]],"date-time":"2019-11-12T16:56:34Z","timestamp":1573577794000},"score":1,"resource":{"primary":{"URL":"http:\/\/jama.jamanetwork.com\/article.aspx?doi=10.1001\/jama.2018.18472"}},"subtitle":["A Systematic Review and Meta-analysis"],"short-title":[],"issued":{"date-parts":[[2018,12,18]]},"references-count":112,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2018,12,18]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2018.18472","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12,18]]}}}